| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/13543784.2014.918953 |
| P698 | PubMed publication ID | 24818644 |
| P50 | author | David Della-Morte | Q79716968 |
| Piero Barbanti | Q57160906 | ||
| P2093 | author name string | Gabriella Egeo | |
| Cinzia Aurilia | |||
| Luisa Fofi | |||
| P2860 | cites work | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Q27860879 |
| Nitric oxide synthases: regulation and function | Q28247092 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura | Q28374438 | ||
| Glyceryl trinitrate induced headache in migraineurs - relation to attack frequency | Q31437297 | ||
| Role of BK(Ca) channels in cephalic vasodilation induced by CGRP, NO and transcranial electrical stimulation in the rat. | Q33294924 | ||
| The role of nitric oxide in nociception | Q34074635 | ||
| Nitric oxide as modulator of neuronal function | Q34183722 | ||
| Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. | Q34270977 | ||
| Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks | Q34469372 | ||
| The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache | Q34826542 | ||
| cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. | Q34831503 | ||
| Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers | Q35116532 | ||
| Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial | Q36052140 | ||
| Role of nitric oxide synthesis in macrophage antimicrobial activity | Q36656920 | ||
| Concepts of neural nitric oxide-mediated transmission | Q37029494 | ||
| NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels | Q37344442 | ||
| Cerebral blood flow regulation by nitric oxide: recent advances | Q37416850 | ||
| Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications | Q37418305 | ||
| No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing | Q37469549 | ||
| Nitric oxide-related drug targets in headache | Q37739589 | ||
| Pain and analgesia: The dual effect of nitric oxide in the nociceptive system | Q37896960 | ||
| Nitric oxide and cyclic GMP signaling pathway as a focus for drug development | Q37897595 | ||
| CGRP and NO in the trigeminal system: mechanisms and role in headache generation | Q38025661 | ||
| Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs | Q38167355 | ||
| Emerging targets in migraine | Q38169593 | ||
| Efficacy and mechanism of anticonvulsant drugs in migraine | Q38185096 | ||
| The Nitric Oxide Hypothesis of Migraine and Other Vascular Headaches | Q41679790 | ||
| Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels | Q42186934 | ||
| Unmasking latent dysnociception in healthy subjects | Q42208181 | ||
| Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack | Q42275734 | ||
| Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. | Q42275969 | ||
| Modulation of nitric oxide synthase by nitric oxide donor compounds in migraine | Q42459229 | ||
| The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. | Q42547439 | ||
| Does the unfavorable pharmacokinetic and pharmacodynamic profile of the iNOS inhibitor GW273629 lead to inefficacy in acute migraine? | Q42613452 | ||
| The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man. | Q42653933 | ||
| CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine. | Q42854065 | ||
| Origin and Co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. | Q43574651 | ||
| Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks | Q43576111 | ||
| Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. | Q43725558 | ||
| Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin | Q43750641 | ||
| Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway? | Q43981820 | ||
| L-Arginine/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content | Q44011881 | ||
| Unilateral cranial autonomic symptoms in migraine. | Q44051813 | ||
| Nitrergic and glutamatergic neuronal mechanisms at the trigeminovascular first-order synapse. | Q44912603 | ||
| Glyceryl trinitrate triggers premonitory symptoms in migraineurs | Q45003191 | ||
| Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia | Q46399203 | ||
| Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. | Q48125110 | ||
| Nitric oxide synthase inhibition lowers activity of neurons with meningeal input in the rat spinal trigeminal nucleus | Q48382239 | ||
| Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation | Q48567339 | ||
| Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. | Q51535876 | ||
| NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models | Q57023928 | ||
| Nitric oxide synthase inhibition in migraine | Q57024918 | ||
| A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks | Q57025038 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 1141-1148 | |
| P577 | publication date | 2014-05-12 | |
| P1433 | published in | Expert Opinion on Investigational Drugs | Q5421208 |
| P1476 | title | Drugs targeting nitric oxide synthase for migraine treatment | |
| P478 | volume | 23 |
| Q36762541 | Andrographis Paniculata shows anti-nociceptive effects in an animal model of sensory hypersensitivity associated with migraine |
| Q93081932 | CGRP and the Trigeminal System in Migraine |
| Q35952529 | Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine |
| Q59203749 | Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study |
| Q38974701 | Headaches: a Review of the Role of Dietary Factors |
| Q47811794 | Modulation of inducible nitric oxide synthase (iNOS) expression and cardiovascular responses during static exercise following iNOS antagonism within the ventrolateral medulla |
| Q91887422 | Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold |
| Q39012465 | Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development. |
| Q38933713 | Sleep, headaches and cerebral energy control: a synoptic view. |
| Q89575368 | Solid-Phase Synthesis of Substrate-Based Dipeptides and Heterocyclic Pseudo-dipeptides as Potential NO Synthase Inhibitors |
| Q57021551 | Triggers, Protectors, and Predictors in Episodic Migraine |
Search more.